Financial News
Headline News about Halozyme Therapeutic
![](https://cdn.benzinga.com/files/images/story/2023/05/31/nasdaq-gde5f50ae6_1280.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2023/01/meme-stock-dice-1600.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Halozyme Therapeutics: Q1 Earnings Insights
May 09, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Halozyme Therapeutics Earnings Preview
May 08, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
The Latest Analyst Ratings for Halozyme Therapeutics
March 16, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
5 Analysts Have This to Say About Halozyme Therapeutics
February 22, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_8712.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2020/08/Stock-regeneron-01-shutt.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Halozyme Therapeutics's Earnings: A Preview
February 20, 2023
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2021/08/Stock-BullPaintedRushing-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/11/image32.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/11/image20.jpeg?width=1200&height=800&fit=crop)
Where Halozyme Therapeutics Stands With Analysts
December 08, 2022
Via Benzinga
5 Analysts Have This to Say About Halozyme Therapeutics
December 08, 2022
Via Benzinga
4 Analysts Have This to Say About Halozyme Therapeutics
November 22, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/11/image17.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/11/image26.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/options_image_2548.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_22686.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 28, 2022
November 28, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/22/argx_logo_light__4922bcd7bc515a6ab1f31330f48d1c5d.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/14/image-amazon-3.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2018/11/Stock-BoardArrowUp-04-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_22263.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Friday
November 25, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/09/image-meta-facebook.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/21/aapharma_10.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_26295.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.